United States

Health News


FDA moves to limit ingredients for bulk drug compounding Mar 23 2018

BOSTON The U.S. Food and Drug Administration on Friday took steps to restrict what pharmaceutical ingredients large compounding pharmacies can use to manufacture drugs in bulk that do not go through the agency's approval processes.

More Headlines

Losing sleep might make it harder to lose body fat

(Reuters Health) - Even when cutting calories helps people lose weight, they may have a harder time getting rid of excess body fat if they don’t get enough sleep, a small experiment suggests.

Mar 23 2018

Abbott's Alere resolves U.S. diagnostic device probe for $33.2 million

BOSTON Alere Inc has agreed to pay $33.2 million to resolve claims it knowingly sold unreliable diagnostic testing devices to hospitals prior to its acquisition by Abbott Laboratories last year, the U.S. Justice Department said on Friday.

Mar 23 2018

EMA panel for conditional OK to Clovis's ovarian cancer drug

A panel of European Medicines Agency (EMA) has recommended granting conditional marketing approval to Clovis Oncology's drug for ovarian cancer, citing anti-tumour activity.

Mar 23 2018

Costly menopause vaginal treatments no better than placebo

(Reuters Health) - For women bothered by vaginal symptoms after menopause, prescription local estrogen treatments and expensive specialty lubricants may provide relief, but no more so than a dummy drug, researchers say.

Mar 23 2018